Skip to main content

Want a detailed portfolio tracker?

Poseida Therapeutics (PSTX) Revenue (2020 - 2024)

Poseida Therapeutics (PSTX) revenue from Sep 30, 2020 to Sep 30, 2024. The TTM Poseida Therapeutics (PSTX) revenue is $151M. You can adjust inflation or export chart.

Annual Revenue

Quarterly Revenue

Poseida Therapeutics (PSTX) Revenue CAGR table

PeriodCAGR
1 Year TTM+203.24%

Annual Revenue change of Poseida Therapeutics (PSTX)

YearRevenueChange
2024$126M+94.53%
2023$65M-50.42%
2022$130M+317.70%
2021$31MN/A
2020$0N/A